Pito Chickering is ranked #1026 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Pito Chickering (Deutsche Bank ) — Analyst Ratings, Accuracy & Track Record

Q: How accurate are Pito Chickering's stock ratings?

About 68% of Pito's ratings were profitable over a one-year hold, with an average return of +1.4% per rating, measured by 13Foresight from historical prices.

Analyst Tracker/Pito Chickering

Pito Chickering

Deutsche Bank

Wall Street Analyst

★★★☆☆

#1026

on 13Foresight · ranked by our own returns

68%

Success Rate

+1.4%

Average Return

17 of 25 calls profitable · -10.9% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compare To ⓘ

🔒 5-year track record is Pro. Showing 1-year — upgrade.

📈 Across the calls we could measure, roughly 68% of Pito Chickering's ratings turned a profit when each position was held for 1 year — averaging +1.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

16 Buy 11 Hold 0 Sell

Pito's Stock Coverage 26 ratings · 2026-06-20

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return
MDLN Medline	May 07, 2026	HOLD	Strong Buy +42.9% avg upside 26 analysts	$42.00 16.90% Upside	-14.1%
DVA DaVita	May 05, 2026	BUY	Hold -23.0% avg upside 17 analysts	$220.00 5.83% Upside	+34.1%
BTSG BrightSpring Health Services, Inc.	May 04, 2026	BUY	Strong Buy -16.3% avg upside 18 analysts	$60.00 9.46% Downside	+20.3%
ACHC Acadia Healthcare	May 01, 2026	BUY	Strong Buy +55.9% avg upside 17 analysts	$32.00 28.70% Upside	-15.6%
SYK Stryker	May 01, 2026	HOLD	Strong Buy +24.0% avg upside 36 analysts	$315.00 2.35% Upside	+3.0%
OPCH Option Care Health	May 01, 2026	BUY	Strong Buy +34.7% avg upside 20 analysts	$26.00 18.25% Upside	+8.4%
BLCO Bausch + Lomb Corporation	Apr 30, 2026	HOLD	Buy +30.8% avg upside 19 analysts	$16.00 7.69% Upside	-4.5%
MMED MiniMed Group, Inc.	Mar 31, 2026	BUY	Strong Buy +47.2% avg upside 13 analysts	$20.00 35.50% Upside	·
AHCO AdaptHealth	Feb 25, 2026	HOLD	Strong Buy +48.1% avg upside 12 analysts	$9.50 1.61% Downside	+4.3%
MD Pediatrix Medical Group	Feb 20, 2026	HOLD	Buy -11.2% avg upside 14 analysts	$19.00 19.58% Downside	+24.8%
BAX Baxter International	Feb 13, 2026	HOLD	Hold +49.6% avg upside 23 analysts	$20.00 0.61% Upside	+5.3%
LMRI Lumexa Imaging Holdings, Inc.	Jan 05, 2026	BUY	Strong Buy +98.9% avg upside 8 analysts	$22.00 133.79% Upside	-53.8%
AVAH Aveanna Healthcare Holdings	Sep 15, 2025	BUY	Buy +16.5% avg upside 17 analysts	$11.50 47.71% Upside	-10.1%
EW Edwards Lifesciences	Jul 25, 2025	BUY	Strong Buy +11.7% avg upside 34 analysts	$94.00 7.50% Upside	+8.3%
DGX Quest Diagnostics	Jul 23, 2025	HOLD	Buy -12.4% avg upside 33 analysts	$178.00 8.64% Downside	+17.6%
DCGO DocGo	Feb 28, 2025	HOLD	Buy +420.4% avg upside 7 analysts	$2.85 444.25% Upside	-76.7%
ZBH Zimmer Biomet Holdings	Feb 07, 2025	HOLD	Buy +27.6% avg upside 37 analysts	$107.00 21.72% Upside	-10.0%
LH Labcorp Holdings	Feb 07, 2025	HOLD	Strong Buy +1.8% avg upside 36 analysts	$248.00 3.06% Downside	+13.8%
BSX Boston Scientific	Jan 10, 2025	BUY	Strong Buy +72.9% avg upside 38 analysts	$108.00 138.51% Upside	+2.9%
PEN Penumbra	Oct 31, 2024	BUY	Buy +4.4% avg upside 23 analysts	$241.00 24.03% Downside	-0.7%
UHS Universal Health	Oct 28, 2024	BUY	Buy +50.5% avg upside 22 analysts	$240.00 69.99% Upside	+7.7%
HCA HCA Healthcare	Oct 08, 2024	BUY	Buy +14.7% avg upside 35 analysts	$441.00 17.50% Upside	+13.3%
MDT Medtronic	Aug 20, 2024	HOLD	Buy +23.5% avg upside 38 analysts	$85.00 7.22% Upside	+12.8%
EHC Encompass Health	Aug 07, 2024	BUY	Strong Buy +13.4% avg upside 22 analysts	$95.00 3.13% Downside	+38.0%
THC Tenet Healthcare	Jul 24, 2024	BUY	Strong Buy +25.9% avg upside 26 analysts	$155.00 10.08% Downside	+2.1%
ACAD ACADIA Pharmaceuticals	Apr 19, 2021	HOLD	Strong Buy +65.9% avg upside 42 analysts	$62.00 186.82% Upside	+4.8%

🔒 21 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Pito Chickering — Frequently Asked Questions

How accurate are Pito Chickering's stock ratings?

Based on the calls 13Foresight could measure, about 68% of Pito's ratings were profitable over a one-year hold, with an average return of +1.4% per rating, or -10.9% versus the S&P 500. We score every analyst the same way, from historical prices.

How is Pito ranked on 13Foresight?

Pito Chickering is currently ranked #1026 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Pito cover?

Pito most recently has ratings on MDLN, DVA, BTSG, ACHC, SYK, OPCH, BLCO, MMED, AHCO, MD, BAX, LMRI and 14 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rating Distribution

Welcome to 13Foresight!